PDC-31

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePDC-31
Drug Alias NamePDC-31PDC-41PHG-113THG-113.31
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionProstanoid FP receptor antagonists
TargetsProstanoid FP receptor
Therapy Area/IndicationsDysmenorrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTheratechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPdc Biotech Gmbh
Active IndicationsN/A
Inactive IndicationsDysmenorrhea

Other Information

ATC CodeN/A
Related LinksN/A